Sponsored

EVA Pharma Signs Voluntary Licensing Agreement With Gilead To Increase Access To Lenacapavir In 120 Countries

EVA Pharma Signs Voluntary Licensing Agreement With Gilead To Increase Access To Lenacapavir In 120 Countries

EVA Pharma has announced a non-exclusive, royalty-free voluntary licensing agreement signed with Gilead, allowing EVA Pharma to manufacture and supply…

2 years ago
Sponsored